Allergy Immunotherapies Market Size Worth US$ 5.0 Billion By 2028 | CAGR of 9.8%
IMARC Group’s latest research report, titled “Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,” the global allergy immunotherapies market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028.
Allergy
immunotherapy, also called desensitization or hypo-sensitization, represents a
long-term medical treatment that usually aims to desensitize the immune system
of an individual against specific allergens that trigger allergy symptoms. It
alters the response of the immune system by gradually increasing the doses of
the allergen. In addition to this, allergy immunotherapy assists in offering
long-term impact, elevating immunological tolerance, reducing inflammation,
changing the course of the disease, improving the quality of life, etc.
Consequently, it is extensively utilized for treating allergic rhinitis,
peanuts allergy, allergic asthma, cat allergy, conjunctivitis, and other kinds
of hypersensitivity.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/allergy-immunotherapies-market/requestsample
Allergy Immunotherapies Market Growth and Development:
The
inflating pollution levels and the rising number of active and passive smokers
are primarily driving the allergy immunotherapy market. Additionally, the
growing healthcare expenditure capacities of individuals, the escalating demand
for long-term treatment options, and the increasing prevalence of allergies, on
account of several lifestyle changes and environmental factors, are further
catalyzing the market growth. Besides this, the launch of favorable policies by
government bodies to spread awareness regarding the high efficacy rates of the
therapy is acting as another significant growth-inducing factor. Moreover,
continuous advancements in drug development technologies and the widespread
adoption of allergy immunotherapy to alter the course of the allergy with
persistent effects are positively influencing the global market. Apart from
this, the development of targeted drugs for allergies in the form of sublingual
immunotherapy (SLIT) tablets and allergen immunotherapy tablets (AITs) is also
stimulating the market growth. Furthermore, extensive investments in R&D
activities are anticipated to fuel the allergy immunotherapy market over the
forecasted period.
Key Players Included in Global Allergy Immunotherapies Market
Research Report:
- ALK-Abello A/S
- Allergy
Therapeutics
- Stallergenes
Greer
- HAL Allergy Group
- DBV Technologies
- Merck Group
- Aimmune
Therapeutics
- Circassia
Pharmaceuticals
- Anergis SA
- Biomay AG
Browse Full Report With TOC: https://www.imarcgroup.com/allergy-immunotherapies-market
Key Market Segmentation:
Breakup by Treatment Type:
- Subcutaneous
Immunotherapy (SCIT)
- Sublingual Immunotherapy
(SLIT)
Breakup by Allergy Type:
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America
(United States, Canada)
- Asia Pacific
(China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany,
France, United Kingdom, Italy, Spain, Others)
- Latin America
(Brazil, Mexico, Others)
- Middle East and
Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
TOC for the Allergy Immunotherapies Market Research Report:
- Preface
- Scope and
Methodology
- Executive Summary
- Introduction
- Global Allergy
Immunotherapies Market
- SWOT Analysis
- Value Chain
Analysis
- Price Analysis
- Competitive
Landscape
Related Report By IMARC Group:
- India
Religious And Spiritual Market Size, Share and Demand 2023-2028
- India
Kitchen Appliances Market Size, Share and Growth 2023-2028
- India
Frozen Finger Chips Market Size, Share and Trends 2023-2028
- India
Mushroom Market Size, Share and Demand 2023-2028
- India
Drones Market Size, Share and Growth 2023-2028
Who we are:
IMARC
Group is a leading market research company that offers management strategy and
market research worldwide. We partner with clients in all sectors and regions
to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s
information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial,
and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
Contact us:
IMARC Group
134 N 4th
St. Brooklyn, NY 11249, USA
Email:
sales@imarcgroup.com
Tel No:(D)
+91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
